Trump’s ‘America First’ agenda on drug pricing could backfire around the world

coapharm2018-05-09T13:06:13+00:00May 9, 2018|

CMS chief criticizes Medicare drug payments for ‘perverse’ incentives

coapharm2018-05-08T12:59:34+00:00May 8, 2018|

Just who gets those big drug rebates?

coapharm2018-05-08T12:58:54+00:00May 8, 2018|

PCMA Head to Step Aside as Pressure Mounts on PBMs

coapharm2018-05-08T12:58:15+00:00May 8, 2018|

HHS seeks 1-year delay on 340B price regulation: 4 things to know

coapharm2018-05-08T12:57:26+00:00May 8, 2018|

EXCLUSIVE: The 340B Program Reached $19.3 Billion in 2017—As Hospitals’ Charity Care Has Dropped

coapharm2018-05-07T13:14:28+00:00May 7, 2018|

Trump often goes off script. What does that mean for his drug pricing speech?

coapharm2018-05-07T13:13:51+00:00May 7, 2018|

Cigna CEO Says Insurer Can Adapt to Drug-Price Shift After Deal

coapharm2018-05-07T13:13:15+00:00May 7, 2018|

The Problem with Prescription Drug Prices

coapharm2018-05-07T13:12:37+00:00May 7, 2018|

White House drug-price initiative to include negotiation tools, list prices, Azar says

coapharm2018-05-03T12:52:35+00:00May 3, 2018|